High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future.
about
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveComparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.Efficacy and outcome of autologous transplantation in rare myelomas.Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.Asiatic acid, a triterpene, inhibits cell proliferation through regulating the expression of focal adhesion kinase in multiple myeloma cells.Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.When to recommend a second autograft in patients with relapsed myeloma?Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patients.Evaluating Treatment Strategies for Spinal Lesions in Multiple Myeloma: A Review of the LiteratureImproved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis
P2860
Q28388806-C1B01837-156C-4EDD-AFF6-19AA8A3DFBC6Q34038564-4B85A757-F186-48F4-BCAF-DE053774C9BCQ34371154-2DD09A4F-55D4-49E2-B3E2-E996FCEEDF90Q36952838-5004FE55-0C41-46E6-BC8F-FF5ED2A4B79DQ41169814-95CA5242-A1EF-450C-AF41-2C6774AD34CCQ41909880-21DA3110-DF6D-4DEF-BC7C-A114998AC961Q42144185-FA56B1B4-821D-49E8-8EC3-FDA1E9372599Q47966106-4665041F-4D86-4C1C-8938-0E4FD4BD16E4Q48250743-61583344-2CA7-4549-A738-CBE5A2A70337Q48921667-56EFC8B6-43BA-4F32-BB04-5952D48310DEQ53245450-17E0EE77-4969-42DF-94C6-92CF1A29901DQ58563417-08FEABF6-E2A4-4741-818E-EB36AACEB23BQ58795876-8EC6FE68-C939-4FD8-8140-72E294761E94
P2860
High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
High-dose treatment with autol ...... ma: past, present, and future.
@en
type
label
High-dose treatment with autol ...... ma: past, present, and future.
@en
prefLabel
High-dose treatment with autol ...... ma: past, present, and future.
@en
P1476
High-dose treatment with autol ...... ma: past, present, and future.
@en
P2093
Bo Björkstrand
Gösta Gahrton
P304
P356
10.1053/J.SEMINHEMATOL.2007.08.010
P577
2007-10-01T00:00:00Z